<DOC>
	<DOCNO>NCT00003518</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase II trial study effectiveness paclitaxel plus gemcitabine treating patient refractory metastatic germ cell tumor respond surgery chemotherapy .</brief_summary>
	<brief_title>Paclitaxel Plus Gemcitabine Treating Patients With Refractory Metastatic Germ Cell Tumors</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate effect gemcitabine plus paclitaxel response rate , duration remission , survival patient refractory germ cell tumor . II . Evaluate toxic effect regimen patient . OUTLINE : Patients receive paclitaxel IV 1 hour follow gemcitabine IV 30 minute day 1 , 8 , 15 4 week course . Treatment repeat maximum six course absence unacceptable toxicity disease progression . Patients follow every 3 month 2 year , every 6 month 3 year , annually thereafter . PROJECTED ACCRUAL : Approximately 44 patient accrued 19 month study .</detailed_description>
	<mesh_term>Neoplasms , Germ Cell Embryonal</mesh_term>
	<mesh_term>Testicular Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically serologically confirm metastatic germ cell neoplasm ( gonadal extragonadal primary ) cure either surgery chemotherapy Seminomas , nonseminomas , ovarian germ cell tumor allow If histologically confirm , require one following : Metastatic lesion chest xray CT scan Rising serum HCG AFP If evidence progressive disease , two additional consecutive determination must exhibit serologic progression Only eligible alternative cause increase serum level absent Failed initial cisplatin combination chemotherapy ( generally bleomycin/etoposide/cisplatin , cisplatin/etoposide , cisplatin/vinblastine , similar regimen ) Failed demonstrated progressive disease follow administration least one `` salvage '' regimen advance germ cell neoplasm Failed three prior regimen define : 25 % increase product perpendicular diameter measurable tumor mass prior therapy , new lesion OR Increasing AFP HCG Disease progression initial induction chemotherapy primary mediastinal nonseminomatous germ cell tumor treat paclitaxel plus gemcitabine secondline therapy ( initial salvage chemotherapy ) PATIENT CHARACTERISTICS : Age : 15 Performance status : ECOG 02 Hematopoietic : WBC least 4,000/mm3 Platelet count least 100,000/mm3 Hepatic : SGOT great 4 time normal Bilirubin great 2 mg/dL Renal : Creatinine great 2.5 mg/dL Other : No active uncontrolled infection Not pregnant nursing Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : See Disease Characteristics At least 3 week since prior chemotherapy recover Endocrine therapy : Not specify Radiotherapy : At least 3 week since prior radiotherapy recover Surgery : At least 3 week since major surgery recover Other : At least 1 week since prior intravenous antibiotic No concurrent intravenous antibiotic</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>stage III malignant testicular germ cell tumor</keyword>
	<keyword>recurrent malignant testicular germ cell tumor</keyword>
	<keyword>stage IV ovarian germ cell tumor</keyword>
	<keyword>recurrent ovarian germ cell tumor</keyword>
</DOC>